Best Pancreatic neuroendocrine tumors Doctors in India for Australians

Dr Chaitainya Borde specialises in Lu-177 RN therapies at HCG Manavata Cancer Centre – a targeted treatment that delivers radiation directly to neuroendocrine tumour cells.

• Performed 30,000+ PET-CT scans for precise tumour mapping and monitoring
• Expert in nuclear cardiology and diverse nuclear scanning techniques
• Administers radioiodine therapies for complex oncological cases
• Published research on nuclear medicine in multiple medical journals
• Focuses on molecular imaging to improve treatment planning

Professor Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre who specialises in precise, non-surgical tumour destruction.

• Treats neuroendocrine tumours using CyberKnife technology – delivers high-dose radiation with sub-millimetre accuracy.
• Expert in robotic radiosurgery for complex tumour sites to spare healthy surrounding tissue.
• Member of the Society for Neuro-Oncology, focusing on tumours affecting the nervous system.
• Board-certified in radiotherapy by the National Board of Examination.
• Provides online consultations for international patients seeking specialist treatment plans.

Dr Shruti Kate is a highly credentialed oncologist at HCG Manavata Cancer Centre who trained at the world-renowned Tata Memorial Hospital in Mumbai.

• Manages endocrine tumours using medical protocols and surgical options like the Whipple procedure
• Specialises in immunotherapy – using the body's immune system to fight advanced cancer cells
• Focuses on metronomic therapy – frequent low-dose chemo to reduce Side effects for patients
• Expert in managing solid tumours and complex paediatric cancer cases
• Member of the European Society for Medical Oncology (ESMO) and ASCO

Professor Shaunak Valame is a dedicated medical oncologist at HCG Manavata Cancer Centre who specialises in targeted therapies for gastrointestinal tumours.

• Trained at the prestigious Indraprastha Apollo Hospital in New Delhi
• Presented research on gastrointestinal cancers at the American Society of Clinical Oncology symposium
• Expert in molecular oncology – uses genetic markers to match patients with precise drug treatments
• Recognised for academic leadership – delivered lectures at the International Winter School of Oncology programmes

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and holds a prestigious fellowship from the Royal College of Surgeons, Edinburgh.

• Trained in surgical oncology at Tata Memorial Hospital – a global leader in cancer care
• Current Professor of Surgical Oncology for the National Board of Examinations
• Oversees complex cases at HCG Manavata Cancer Centre, which he founded
• Leads clinical research as an investigator for over 200 oncology trials
• Member of the Royal College of Surgeons, Edinburgh